archive-au.com » AU » C » CSL.COM.AU

Total: 502

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • CSL Limited's Board and Management Group
    Industry resident in USA Independent No Chief Executive Office and Managing Director Paul Perreault was appointed to the CSL Board in February 2013 and is the Chief Executive Officer and Managing Director Paul joined a CSL predecessor company in 1997 and has held senior roles in sales marketing and operations with his most recent prior position being President CSL Behring He has also worked in senior leadership roles with Wyeth Centeon Aventis Bioservices and Aventis Behring Paul was previously Chairman of the Global Board for the Plasma Protein Therapeutics Association He has had more that 30 years experience in the global healthcare industry Mr Perreault is a member of the Innovation and Development Committee John Akehurst MA Oxon FIMechE Age 64 Engineering and Management resident in Western Australia Independent Yes Mr Akehurst was appointed to the CSL Board in April 2004 He had 30 years executive experience in the international hydrocarbon industry including seven years as Managing Director and CEO of Woodside Petroleum Ltd Mr Akehurst is a member of the Board of the Reserve Bank of Australia and is a Director of Origin Energy Limited and Transform Pty Ltd He was formerly Chairman of Alinta Limited and of Coogee Resources Limited and is a former Director of Oil Search Limited Mr Akehurst is Chairman of the National Centre for Asbestos Related Diseases and the Fortitude Foundation Mr Akehurst is Chairman of the Human Resources and Remuneration Committee David Anstice BEc Age 65 International Pharmaceutical Industry resident in Pennsylvania USA Inependent Yes Mr Anstice was appointed to the CSL Board in September 2008 He was a long time member of the Board of Directors and Executive Committee of the US Biotechnology Industry Organisation and has over 40 years experience in the global pharmaceutical industry Until August 2008 Mr Anstice was for many years a senior executive of Merck Co Inc serving at various times as President of Merck Human Health for US Canada Latin America Europe Japan and Asia and upon retirement was an Executive Vice President He is a Director of Alkermes Plc Dublin Ireland and a Director of the United States Studies Centre at the University of Sydney Mr Anstice is a member of the Human Resources and Remuneration Committee and the Innovation and Development Committee Bruce Brook BCom BAcc FCA MAICD Age 58 Finance and Management resident in Victoria Independent Yes Mr Brook was appointed to the CSL Board in August 2011 He is currently Chairman of Programmed Maintenance Services Limited and a Director of Boart Longyear Limited and Newmont Mining Corporation Mr Brook has previously been Chairman of Energy Developments Limited and a Director of Lihir Gold Limited and Consolidated Minerals Limited During his executive career he was Chief Financial Officer of WMC Resources Limited and prior to that the Deputy Chief Financial Officer of the ANZ Banking Group Mr Brook is Chairman of the Audit and Risk Management Committee Marie McDonald BSc Hon LLB Hon Age 57 Law resident in Victoria Independent Yes Ms McDonald

    Original URL path: http://www.csl.com.au/about/board-management.htm (2014-01-05)
    Open archived version from archive


  • The governance of CSL Limited
    that the Company complies with the ASX Corporate Governance Council s Revised Corporate Governance Principles and Recommendations Furthermore the Board and management are committed to continuing to review the Company s corporate governance practices in response to changes in market conditions or recognised best practices CSL Limited Constitution 0 43MB Corporate Governance Statement CSL Compliance Checklist Table Board and Board Committees The Board is responsible for oversight of the management of the Company and providing strategic direction It monitors operational and financial performance human resources policies and practices and approves the Company s budgets and business plans It is also responsible for overseeing the Company s risk management financial reporting and compliance framework The Board has a formal Charter documenting its membership operating procedures and the appointment of responsibilities between the Board and management CSL Board Charter 0 11Mb The Board has established a number of standing committees as an efficient mechanism for considering detailed issues and where appropriate making recommendations for consideration by the Board These committees have charters setting out matters relevant to the composition responsibilities and membership of each committee Audit and Risk Management Committee Charter 0 04Mb Human Resources and Remuneration Committee Charter 0 06Mb Innovation

    Original URL path: http://www.csl.com.au/about/governance.htm (2014-01-05)
    Open archived version from archive

  • The values and ethics of CSL Limited
    Development Business Development Investors Corporate Responsibility Careers Newsroom Contact CSL Home About CSL Values and Ethics Values Ethics The CSL Group Values set a foundation for working across the organisation and serve as a tool in decision making in the diverse businesses that form the CSL Group In 2002 the Company set out to identify a set of values common to the diverse business units that form the CSL Group

    Original URL path: http://www.csl.com.au/about/values-ethics.htm (2014-01-05)
    Open archived version from archive

  • Code of Responsible Business Practice
    its responsibilities to shareholders and the financial community Rules guiding employees and directors towards ethical decisions in situations of potential conflict of interest political involvement bribery and financial inducements Workplace relations principles regarded by the Company as fundamental including mutual respect anti discrimination and freedom of association Commitment to adherence to health and safety standards both of products through compliance with manufacturing and other best practice standards and In the provision of safe employee work environments Practices for responsible environmental management and Guidance for beneficial interactive relationships with the communities in which CSL operates and collaboration throughout the organisation We have developed this code and supplementary policies and procedures to ensure that Our customers and the broader community can be confident that CSL is committed to operating with the highest integrity at all times Our contractors suppliers and distributors know what to expect from a business relationship with CSL and the expectations we have of them and Our employees understand both their obligations to CSL and CSL s obligations to them Raising a business conduct concern We encourage a workplace where people seek assistance if they are uncertain about what to do We also encourage those with whom we interact

    Original URL path: http://www.csl.com.au/about/code-of-responsible-business-practice.htm (2014-01-05)
    Open archived version from archive

  • The History of CSL Limited
    and Development Business Development Investors Corporate Responsibility Careers Newsroom Contact CSL Home About CSL Our History Our History Also in this section 1900 1919 1920 1939 1940 1959 1960 1979 1980 1999 2000 present The Commonwealth Serum Laboratories was established in Australia in 1916 to service the health needs of a nation isolated by war CSL Limited was then incorporated in 1991 and listed on the Australian Stock Exchange in

    Original URL path: http://www.csl.com.au/about/history.htm (2014-01-05)
    Open archived version from archive

  • CSL Behring
    Research and Development Business Development Investors Corporate Responsibility Careers Newsroom Contact CSL Home Our Businesses CSL Behring CSL Behring CSL Behring is a leader in the plasma protein therapeutics industry Committed to saving lives and improving the quality of life for people with rare and serious diseases the company manufactures and markets a range of plasma derived and recombinant therapies worldwide CSL Behring therapies are used around the world to treat coagulation disorders including hemophilia and von Willebrand disease primary immune deficiencies hereditary angioedema and inherited respiratory disease and neurological disorders in certain markets The company s products are also used in cardiac surgery organ transplantation burn treatment and to prevent hemolytic diseases in the newborn Our products are produced at facilities in Bern Switzerland Marburg Germany Kankakee Illinois and Broadmeadows Australia in accordance with international safety and quality standards Additionally CSL Behring operates one of the world s largest plasma collection networks CSL Plasma CSL Behring is a subsidiary of CSL Limited a biopharmaceutical company which operates worldwide from its headquarters in Melbourne Australia For more information about the company please visit the global CSL Behring website or the CSL Behring Australia website In December 2012 CSL announced that

    Original URL path: http://www.csl.com.au/businesses/csl-behring.htm (2014-01-05)
    Open archived version from archive

  • CSL Plasma
    One of the largest collectors of human blood plasma in the world CSL Plasma sources the plasma required through its plasma collection operations and commercial purchases Globally more than 400 000 donors provide the plasma used to produce a range of life saving products for critically ill patients CSL Plasma offers a reliable and secure source of plasma for those essential medications The plasma collection business is based at Boca

    Original URL path: http://www.csl.com.au/businesses/csl-behring/csl-plasma.htm (2014-01-05)
    Open archived version from archive

  • bioCSL's Immunohaematology business
    Log in to the IH Portal Contact bioCSL Immunohaematology NICE 2013 Meeting Meeting Notice Registration Pack Registration Form The Immunohaematology business is a stand alone business unit operating under bioCSL formerly CSL Biotherapies Our core skills include the manufacture of Reagent Red Blood Cells RRBCs monoclonal antibodies and the production of reagents and ancillary products for immunohaematology laboratories bioCSL Immunohaematology works closely with the Australian Commonwealth Government Department of Health

    Original URL path: http://www.csl.com.au/businesses/csl-biotherapies-immunohaematology.htm (2014-01-05)
    Open archived version from archive